ClinicalTrials.govpublic full text
Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients
covid-19, cronovirus, human dental pulp stem cells, dental stem cell banking, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1030418
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.